New hope for leukemia patients: experimental combo targets relapsed AML
Disease control
Recruiting now
This study tests a new two-drug combination for adults with acute myeloid leukemia that has come back or not responded to prior treatments. The drugs, DFP-10917 and venetoclax, are given together to try to control the cancer. About 39 participants will receive the treatment to se…
Phase: PHASE1, PHASE2 • Sponsor: Delta-Fly Pharma, Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC